| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Lower serum magnesium is associated with cardiovascular risk factors and mortality in haemodialysis patients.
|
Blood Purif
|
2015
|
1.51
|
|
2
|
Plant-pollinator networks: adding the pollinator's perspective.
|
Ecol Lett
|
2009
|
1.34
|
|
3
|
Post-genomic analyses of fungal lignocellulosic biomass degradation reveal the unexpected potential of the plant pathogen Ustilago maydis.
|
BMC Genomics
|
2012
|
1.34
|
|
4
|
Comparative evaluation of three automated systems for DNA extraction in conjunction with three commercially available real-time PCR assays for quantitation of plasma Cytomegalovirus DNAemia in allogeneic stem cell transplant recipients.
|
J Clin Microbiol
|
2011
|
1.27
|
|
5
|
Virological and immunological features of active cytomegalovirus infection in nonimmunosuppressed patients in a surgical and trauma intensive care unit.
|
J Med Virol
|
2010
|
1.15
|
|
6
|
Quantification of DNA in plasma by an automated real-time PCR assay (cytomegalovirus PCR kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients.
|
J Clin Microbiol
|
2008
|
1.13
|
|
7
|
Comparison of three statistical methods for establishing tentative wild-type population and epidemiological cutoff values for echinocandins, amphotericin B, flucytosine, and six Candida species as determined by the colorimetric Sensititre YeastOne method.
|
J Clin Microbiol
|
2012
|
1.12
|
|
8
|
Diagnostic accuracy and potential clinical value of the LightCycler SeptiFast assay in the management of bloodstream infections occurring in neutropenic and critically ill patients.
|
Int J Infect Dis
|
2011
|
1.05
|
|
9
|
Feruloyl esterases as a tool for the release of phenolic compounds from agro-industrial by-products.
|
Carbohydr Res
|
2006
|
1.04
|
|
10
|
Comparison of the new Abbott Real Time CMV assay and the Abbott CMV PCR Kit for the quantitation of plasma cytomegalovirus DNAemia.
|
Diagn Microbiol Infect Dis
|
2012
|
1.02
|
|
11
|
Dynamics of cytomegalovirus (CMV) plasma DNAemia in initial and recurrent episodes of active CMV infection in the allogeneic stem cell transplantation setting: implications for designing preemptive antiviral therapy strategies.
|
Biol Blood Marrow Transplant
|
2011
|
1.00
|
|
12
|
Concurrent detection of human herpesvirus type 6 and measles-specific IgMs during acute exanthematic human parvovirus B19 infection.
|
J Med Virol
|
2006
|
0.98
|
|
13
|
Pharmacokinetics of anidulafungin during albumin dialysis.
|
Crit Care
|
2014
|
0.93
|
|
14
|
Characterization of a broad-specificity β-glucanase acting on β-(1,3)-, β-(1,4)-, and β-(1,6)-glucans that defines a new glycoside hydrolase family.
|
Appl Environ Microbiol
|
2012
|
0.92
|
|
15
|
Production of a chimeric enzyme tool associating the Trichoderma reesei swollenin with the Aspergillus niger feruloyl esterase A for release of ferulic acid.
|
Appl Microbiol Biotechnol
|
2006
|
0.91
|
|
16
|
Kinetics of cytomegalovirus (CMV) pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells during episodes of viral DNAemia in allogeneic stem cell transplant recipients: potential implications for the management of active CMV infection.
|
J Med Virol
|
2010
|
0.91
|
|
17
|
Exploring laccase-like multicopper oxidase genes from the ascomycete Trichoderma reesei: a functional, phylogenetic and evolutionary study.
|
BMC Biochem
|
2010
|
0.91
|
|
18
|
Assessment of Epstein-Barr virus (EBV) serostatus by enzyme immunoassays: plausibility of the isolated EBNA-1 IgG positive serological profile.
|
J Infect
|
2008
|
0.91
|
|
19
|
Enumeration of cytomegalovirus-specific interferongamma CD8+ and CD4+ T cells early after allogeneic stem cell transplantation may identify patients at risk of active cytomegalovirus infection.
|
Haematologica
|
2008
|
0.90
|
|
20
|
A thermostable GH45 endoglucanase from yeast: impact of its atypical multimodularity on activity.
|
Microb Cell Fact
|
2011
|
0.90
|
|
21
|
Early kinetics of plasma cytomegalovirus DNA load in allogeneic stem cell transplant recipients in the era of highly sensitive real-time PCR assays: does it have any clinical value?
|
J Clin Microbiol
|
2013
|
0.90
|
|
22
|
Immunological monitoring for guidance of preemptive antiviral therapy for active cytomegalovirus infection in allogeneic stem-cell transplant recipients: a pilot experience.
|
Transplantation
|
2011
|
0.89
|
|
23
|
GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients.
|
Enferm Infecc Microbiol Clin
|
2011
|
0.88
|
|
24
|
Performance of the Epstein-Barr virus and herpes simplex virus immunoglobulin m assays on the liaison platform with sera from patients displaying acute parvovirus B19 infection.
|
Clin Vaccine Immunol
|
2009
|
0.88
|
|
25
|
Evaluation of an immunofiltration assay that detects immunoglobulin M antibodies against the ZEBRA protein for the diagnosis of Epstein-Barr virus infectious mononucleosis in immunocompetent patients.
|
Clin Vaccine Immunol
|
2009
|
0.88
|
|
26
|
Exploring the natural fungal biodiversity of tropical and temperate forests toward improvement of biomass conversion.
|
Appl Environ Microbiol
|
2012
|
0.88
|
|
27
|
An assessment of the effect of human herpesvirus-6 replication on active cytomegalovirus infection after allogeneic stem cell transplantation.
|
Biol Blood Marrow Transplant
|
2010
|
0.87
|
|
28
|
Positive result of the Aspergillus galactomannan antigen assay using bronchoalveolar lavage fluid from a patient with an invasive infection due to Lichtheimia ramosa.
|
J Clin Microbiol
|
2010
|
0.87
|
|
29
|
Performance of the QuantiFERON-cytomegalovirus (CMV) assay for detection and estimation of the magnitude and functionality of the CMV-specific gamma interferon-producing CD8(+) T-cell response in allogeneic stem cell transplant recipients.
|
Clin Vaccine Immunol
|
2012
|
0.87
|
|
30
|
Effect of the IL28B Rs12979860 C/T polymorphism on the incidence and features of active cytomegalovirus infection in allogeneic stem cell transplant patients.
|
J Med Virol
|
2013
|
0.85
|
|
31
|
Functional profile of cytomegalovirus (CMV)-specific CD8+ T cells and kinetics of NKG2C+ NK cells associated with the resolution of CMV DNAemia in allogeneic stem cell transplant recipients.
|
J Med Virol
|
2012
|
0.85
|
|
32
|
Pathogen safety of long-term treatments for bleeding disorders: still relevant to current practice.
|
Haematologica
|
2013
|
0.84
|
|
33
|
Differences in cytomegalovirus plasma viral loads measured in allogeneic hematopoietic stem cell transplant recipients using two commercial real-time PCR assays.
|
J Clin Virol
|
2010
|
0.84
|
|
34
|
A novel glucose dehydrogenase from the white-rot fungus Pycnoporus cinnabarinus: production in Aspergillus niger and physicochemical characterization of the recombinant enzyme.
|
Appl Microbiol Biotechnol
|
2014
|
0.83
|
|
35
|
Performance of an automated human immunodeficiency virus (HIV) antigen/antibody combined assay for prenatal screening for HIV infection in pregnant women.
|
J Med Microbiol
|
2009
|
0.83
|
|
36
|
Enzymatic synthesis of model substrates recognized by glucuronoyl esterases from Podospora anserina and Myceliophthora thermophila.
|
Appl Microbiol Biotechnol
|
2014
|
0.83
|
|
37
|
YeastIP: a database for identification and phylogeny of Saccharomycotina yeasts.
|
FEMS Yeast Res
|
2012
|
0.83
|
|
38
|
Real-time reverse-transcription PCR in the diagnosis of influenza A (H1N1)v in intensive care unit adult patients.
|
Crit Care
|
2009
|
0.83
|
|
39
|
Performance of the LightCycler SeptiFast test Mgrade in detecting microbial pathogens in purulent fluids.
|
J Clin Microbiol
|
2011
|
0.83
|
|
40
|
Evaluation of cytomegalovirus (CMV)-specific T-cell immunity for the assessment of the risk of active CMV infection in non-immunosuppressed surgical and trauma intensive care unit patients.
|
J Med Virol
|
2013
|
0.82
|
|
41
|
Design and production in Aspergillus niger of a chimeric protein associating a fungal feruloyl esterase and a clostridial dockerin domain.
|
Appl Environ Microbiol
|
2004
|
0.82
|
|
42
|
Purification and characterization of a chlorogenic acid hydrolase from Aspergillus niger catalysing the hydrolysis of chlorogenic acid.
|
J Biotechnol
|
2005
|
0.82
|
|
43
|
Construction of engineered bifunctional enzymes and their overproduction in Aspergillus niger for improved enzymatic tools to degrade agricultural by-products.
|
Appl Environ Microbiol
|
2005
|
0.82
|
|
44
|
Phylogeographic relationships in the polypore fungus Pycnoporus inferred from molecular data.
|
FEMS Microbiol Lett
|
2011
|
0.81
|
|
45
|
Differences in vancomycin minimum inhibitory concentrations for Staphylococcus aureus obtained with the automated Phoenix™ system, the Clinical and Laboratory Standards Institute broth microdilution method and the standard Etest.
|
Int J Antimicrob Agents
|
2011
|
0.80
|
|
46
|
PCR detection of viral DNA in serum as an ancillary analysis for the diagnosis of acute mononucleosis-like syndrome due to human cytomegalovirus (HCMV) in immunocompetent patients.
|
J Clin Virol
|
2005
|
0.79
|
|
47
|
Gene overexpression and biochemical characterization of the biotechnologically relevant chlorogenic acid hydrolase from Aspergillus niger.
|
Appl Environ Microbiol
|
2007
|
0.79
|
|
48
|
Exploration of members of Aspergillus sections Nigri, Flavi, and Terrei for feruloyl esterase production.
|
Can J Microbiol
|
2006
|
0.79
|
|
49
|
Frequent detection of cytomegalovirus (CMV) DNA in the lower respiratory tract in CMV-seropositive pediatric patients with underlying chronic bronchopulmonary diseases lacking canonical immunosuppression.
|
J Med Virol
|
2013
|
0.79
|
|
50
|
Immunological insights into the pathogenesis of active CMV infection in non-immunosuppressed critically ill patients.
|
J Med Virol
|
2011
|
0.79
|
|
51
|
Performance of an immunofiltration assay detecting IgM antibodies against ZEBRA and viral capsid p18 proteins (Immunoquick(®) filtration EBV M) for the diagnosis of heterophile antibody-negative primary Epstein-Barr virus infection in children.
|
J Clin Virol
|
2011
|
0.78
|
|
52
|
Phylogenetic analysis of the Aspergillus niger aggregate in relation to feruloyl esterase activity.
|
Res Microbiol
|
2007
|
0.78
|
|
53
|
Evaluation of the Architect Epstein-Barr Virus (EBV) viral capsid antigen (VCA) IgG, VCA IgM, and EBV nuclear antigen 1 IgG chemiluminescent immunoassays for detection of EBV antibodies and categorization of EBV infection status using immunofluorescence assays as the reference method.
|
Clin Vaccine Immunol
|
2014
|
0.78
|
|
54
|
New process for fungal delignification of sugar-cane bagasse and simultaneous production of laccase in a vapor phase bioreactor.
|
J Agric Food Chem
|
2006
|
0.78
|
|
55
|
An evaluation of the role of NKG2C+ natural killer cells in protection from cytomegalovirus DNAemia early following allogeneic stem cell transplantation.
|
J Med Virol
|
2013
|
0.78
|
|
56
|
Looking for biological factors to predict the risk of active cytomegalovirus infection in non-immunosuppressed critically ill patients.
|
J Med Virol
|
2013
|
0.77
|
|
57
|
Functional living biointerphases.
|
Adv Healthc Mater
|
2013
|
0.77
|
|
58
|
Serum heat shock protein 60 in acute heart failure: a new biomarker?
|
Congest Heart Fail
|
2012
|
0.76
|
|
59
|
Incidence and dynamics of active cytomegalovirus infection in allogeneic stem cell transplant patients according to single nucleotide polymorphisms in donor and recipient CCR5, MCP-1, IL-10, and TLR9 genes.
|
J Med Virol
|
2014
|
0.76
|
|
60
|
Prevalence and prognostic implications of active cytomegalovirus infection in patients with acute heart failure.
|
Clin Sci (Lond)
|
2010
|
0.76
|
|
61
|
Pathogen safety of long-term treatments for bleeding disorders: (un)predictable risks and evolving threats.
|
Semin Thromb Hemost
|
2013
|
0.76
|
|
62
|
Assessment of human cytomegalovirus specific T cell immunity in human immunodeficiency virus infected patients in different disease stages following HAART and in long-term non-progressors.
|
J Med Virol
|
2004
|
0.75
|
|
63
|
Epstein-Barr virus DNAemia is an early surrogate marker of the net state of immunosuppresion in solid organ transplant recipients.
|
Transplantation
|
2013
|
0.75
|
|
64
|
Lack of evidence of neoantigen formation in different batches of a double-virus inactivated factor VIII concentrate manufactured in Argentina.
|
Blood Transfus
|
2010
|
0.75
|
|
65
|
Need to evaluate the performance of real-time PCR assays for the quantitation of cytomegalovirus DNA load in lower respiratory tract specimens.
|
Crit Care
|
2013
|
0.75
|
|
66
|
Comparison of BinaxNOW Influenza A&B assay and real-time reverse transcription polymerase chain reaction for diagnosis of influenza A pandemic (H1N1) 2009 virus infection in adult patients.
|
Diagn Microbiol Infect Dis
|
2010
|
0.75
|
|
67
|
Effect of cytomegalovirus (CMV) serostatus on the incidence and virological features of active CMV infection in allogeneic stem cell transplant recipients.
|
Clin Infect Dis
|
2011
|
0.75
|
|
68
|
Chromogenic substrates for feruloyl esterases.
|
Carbohydr Res
|
2007
|
0.75
|
|
69
|
Application of a 5-bromo-2'-deoxyuridine ELISA for measuring the lymphoproliferative response to human cytomegalovirus in HIV-1-infected patients.
|
J Virol Methods
|
2002
|
0.75
|
|
70
|
Set of interviews.
|
Wkly Epidemiol Rec
|
2015
|
0.75
|
|
71
|
Becton Dickinson Directigen EZ Flu A+B assay in the diagnosis of pandemic influenza A H1N1 2009 virus infection in adult patients.
|
Influenza Other Respir Viruses
|
2011
|
0.75
|
|
72
|
Optimizing the use of darbepoetin-α with a split strategy: a concept change
.
|
Clin Nephrol
|
2017
|
0.75
|
|
73
|
Human cytomegalovirus (HCMV)-specific CD4+ T lymphocyte response in AIDS patients with no past or current HCMV disease following HAART.
|
J Clin Virol
|
2004
|
0.75
|
|
74
|
New cultural approaches for microaerophilic hyperthermophiles.
|
Curr Microbiol
|
2010
|
0.75
|
|
75
|
Sensitivity of a marketed immunochromatographic assay specifically targeting the pandemic influenza A/H1N1 2009 virus.
|
Diagn Microbiol Infect Dis
|
2010
|
0.75
|
|
76
|
Low rate of detection of active cytomegalovirus (CMV) infection early following acute myocardial infarction.
|
Atherosclerosis
|
2012
|
0.75
|
|
77
|
Cytomegalovirus infection in solid organ transplantation.
|
Enferm Infecc Microbiol Clin
|
2012
|
0.75
|
|
78
|
Plasma metabolomics profiling for the prediction of cytomegalovirus DNAemia and analysis of virus–host interaction in allogeneic stem cell transplant recipients.
|
J Gen Virol
|
2015
|
0.75
|
|
79
|
Reconstitution of lymphocyte populations and cytomegalovirus viremia or disease after allogeneic peripheral blood stem cell transplantation.
|
J Med Virol
|
2003
|
0.75
|
|
80
|
Calcium Acetate/Magnesium Carbonate and Cardiovascular Risk Factors in Chronic Hemodialysis Patients.
|
Nephron
|
2016
|
0.75
|
|
81
|
An investigation on the relationship between the occurrence of CMV DNAemia and the development of invasive aspergillosis in the allogeneic stem cell transplantation setting.
|
J Med Virol
|
2013
|
0.75
|
|
82
|
Active cytomegalovirus infection is not a risk factor for Epstein-Barr virus DNAemia in the allogeneic stem cell transplantation setting.
|
Clin Transplant
|
2014
|
0.75
|
|
83
|
New chromogenic substrates for feruloyl esterases.
|
Org Biomol Chem
|
2008
|
0.75
|